ONCO

Onconetix Inc. (ONCO) | Rumor.io

Onconetix

ONCO

Attention (50-day avg)0%

Attention rank (50-day avg)#1,137

Bullish sentiment (50-day avg)74%

Price to earnings ratio0

Market capitalization4.9M

Earnings per share749.1

Dividend yield (TTM)—

Revenue (annual)815.4K

Net income (annual)-14M

Social

What share of all stock conversation is about ONCO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.02	0.01% +0.01	0% +0	0% 0

Sep 29

ONCO's price has been discounted, with some users mentioning buying at $1.04 and others expressing disappointment at the current price.
Some users believe ONCO is still a good investment opportunity, citing it as a potential "buy" despite its current state, and others are hopeful for a price increase above $1.10.
There are concerns and criticisms about ONCO's practices and management, with some users calling it a "scam" and referencing "active dilution" and "front-loaded" practices.

Generated by AI

Sentiment

Of the messages about ONCO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	66.67% -31.77	76.46% -23.54	72.51% -25.6	78.57% -8.54
Bearish	33.33% +31.77	23.54% +23.54	27.49% +25.6	21.43% +8.54

Bullish· Sep 28

The company has ten times its current market capitalization in cash reserves, setting the stage for a significant increase in the share price.
The stock has been driven down from $100 on low volume, flying under the radar, but now it's undergoing a major repricing.
The company is primed to explode at market open, with a short squeeze guarantee, and the potential to break past $20 and reach $3.

Bearish· Sep 25

Onconetix, Inc. (ONCO) is facing significant resistance at $1.15, which is hindering its price action.
The company's stock is experiencing a "usual Friday sell off" and may not recover much by the end of the day.
Onconetix, Inc. is likely to continue its downward trend due to factors such as interest rates, oil prices, and war, which are dictating the market.

Generated by AI

Topics

Of the messages about ONCO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	24.39%	20.81%	49.44%
Technical Analysis	100%	2.44%	2.35%	31.99%
Analysts	0%	36.59%	37.92%	9.08%
Macro	0%	36.59%	37.92%	9.08%
Controversies	0%	0%	1.01%	0.32%
Earnings	0%	0%	0%	0.08%

Announcements· Apr 15

Onconetix, Inc. (ONCO) has shipped its first AI Humanoid Robot to a $40 billion customer, Ericsson.
The company has a definitive share exchange agreement to acquire 100% of Realbotix LLC in an all-stock transaction, subject to customary conditions including shareholder and regulatory approvals.
ONCO has a low market cap of $550,000, a high short interest of 107%, and is a high-risk, speculative investment opportunity tied to the successful execution of the Realbotix reverse merger and commercialization of robotics technology.

Technical Analysis· Apr 9

$ONCO has seen a +113.27% surge, breaking through $1.62 resistance, with a next target of $4.48.
The stock has a massive 172.76M volume, indicating a significant momentum shift, with a technical target of $4.40.
Onconetix, Inc. ($ONCO) has formed a triangle pattern, indicating a potential lift off, with a strong test of resistance expected soon.

Generated by AI

Community

Of the messages about ONCO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	52.94%	35.83%	36.09%	22.18%
Newcomers	47.06%	64.17%	63.91%	77.82%

Regulars· Sep 29

ONCO's price has been fluctuating, with some participants still holding a bullish stance despite previous losses.
The company is under scrutiny for alleged dilution of shares, with some participants speculating about the involvement of key individuals, including Eric.
There are rumors of a potential takeover by XBOT, a robotics company, which could lead to ONCO's delisting if not resolved.

Newcomers· Sep 28

Newcomers are buying ONCO, citing its potential to run hard and increase in value, with some predicting it could shoot to $3.
Some users are sharing their experiences with ONCO, including holding through weekends and seeing positive results, and predicting a breakout after a few days of teasing.
There is a premarket alert about ONCO's significant price increase, with a 31% jump from $1.11 to $1.38 in a short period, and users are reacting to this news.

Generated by AI

Gainers Onconetix (NASDAQ:ONCO) stock increased by 10.3% to $1.14 during Friday's after-market session. The market value of their outstanding shares is at $3.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved

4d agoBenzinga

12 Health Care Stocks Moving In Thursday's After-Market Session - Prime Medicine (NASDAQ:PRME), Onconetix

Gainers Prime Medicine (NASDAQ:PRME) shares increased by 13.0% to $3.47 during Thursday's after-market session. The market value of their outstanding shares is at $567.7 million. Onconetix (NASDAQ:ONCO) stock rose

5d agoBenzinga

SRX Global Makes Investment in Onconetix

SRX Global (SRXH) said Thursday it has made an investment in Onconetix (ONCO), which is in the midst

5d agoYahoo Finance

SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)

5d agoYahoo Finance

CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest Bearing Facility Is Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition CINCINNATI, Ohio, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") today announced that it has provided a strategic bridge financing facility of up to $5,000,000 to Realbotix LLC ("Realbotix"), the target of its previously announced pending acquisi

15d agoYahoo Finance Australia

Onconetix provides $2.5M bridge financing to Realbotix

15d agoInvesting.com

Also Discussed

Investors talking about ONCO also mention

#	Name	Attention
1	Flash Sports & Media, Inc.UGRO	0%new
2	Linkers Industries LimitedLNKS	0%0
3	Cheetah Net Supply Chain Service Inc.CTNT	0.02%-0.01
4	UOKA - MDJM Ltd	——
5	Chanson International Holding Class A Ordinary SharesCHSN	0%0
6	Sky Harbour Group Corp.SKYH	0%new
7	Xiao-I Corporation American Depositary SharesAIXI	0.01%+0.01
8	Huachen AI Parking Management Technology Holding Co., Ltd. Class A Ordinary SharesHCAI	0%new
9	Pro-Dex Inc.PDEX	0%0
10	Akanda Corp.AKAN	0%+0

Onconetix Inc.

Healthcare
Biotechnology

Onconetix Inc. is a commercial-stage biotechnology company focused on solutions for men’s health and oncology. The company develops and commercializes proprietary therapeutics, diagnostics, and clinician-focused services, with an emphasis on prostate cancer and related urologic conditions. Its product portfolio includes Proclarix, a blood-based diagnostic test used in prostate cancer assessment, and Entadfi, an oral therapy for benign prostatic hyperplasia. Onconetix also works on expanding its oncology diagnostics and treatment offerings through research, development, and commercialization activities across key international markets, including the United States and Europe. Headquartered in Cincinnati, Ohio, Onconetix Inc. operates at the intersection of diagnostic testing and therapeutic care, serving healthcare providers and patients in specialized cancer and men’s health settings.

Website

Location

201 East Fifth Street

Cincinnati, OH, 45202

United States

Social

What share of all stock conversation is about ONCO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.02	0.01% +0.01	0% +0	0% 0

Sep 29

ONCO's price has been discounted, with some users mentioning buying at $1.04 and others expressing disappointment at the current price.
Some users believe ONCO is still a good investment opportunity, citing it as a potential "buy" despite its current state, and others are hopeful for a price increase above $1.10.
There are concerns and criticisms about ONCO's practices and management, with some users calling it a "scam" and referencing "active dilution" and "front-loaded" practices.

Generated by AI

Sentiment

Of the messages about ONCO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	66.67% -31.77	76.46% -23.54	72.51% -25.6	78.57% -8.54
Bearish	33.33% +31.77	23.54% +23.54	27.49% +25.6	21.43% +8.54

Bullish· Sep 28

The company has ten times its current market capitalization in cash reserves, setting the stage for a significant increase in the share price.
The stock has been driven down from $100 on low volume, flying under the radar, but now it's undergoing a major repricing.
The company is primed to explode at market open, with a short squeeze guarantee, and the potential to break past $20 and reach $3.

Bearish· Sep 25

Onconetix, Inc. (ONCO) is facing significant resistance at $1.15, which is hindering its price action.
The company's stock is experiencing a "usual Friday sell off" and may not recover much by the end of the day.
Onconetix, Inc. is likely to continue its downward trend due to factors such as interest rates, oil prices, and war, which are dictating the market.

Generated by AI

Topics

Of the messages about ONCO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	24.39%	20.81%	49.44%
Technical Analysis	100%	2.44%	2.35%	31.99%
Analysts	0%	36.59%	37.92%	9.08%
Macro	0%	36.59%	37.92%	9.08%
Controversies	0%	0%	1.01%	0.32%
Earnings	0%	0%	0%	0.08%

Announcements· Apr 15

Onconetix, Inc. (ONCO) has shipped its first AI Humanoid Robot to a $40 billion customer, Ericsson.
The company has a definitive share exchange agreement to acquire 100% of Realbotix LLC in an all-stock transaction, subject to customary conditions including shareholder and regulatory approvals.
ONCO has a low market cap of $550,000, a high short interest of 107%, and is a high-risk, speculative investment opportunity tied to the successful execution of the Realbotix reverse merger and commercialization of robotics technology.

Technical Analysis· Apr 9

$ONCO has seen a +113.27% surge, breaking through $1.62 resistance, with a next target of $4.48.
The stock has a massive 172.76M volume, indicating a significant momentum shift, with a technical target of $4.40.
Onconetix, Inc. ($ONCO) has formed a triangle pattern, indicating a potential lift off, with a strong test of resistance expected soon.

Generated by AI

Community

Of the messages about ONCO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	52.94%	35.83%	36.09%	22.18%
Newcomers	47.06%	64.17%	63.91%	77.82%

Regulars· Sep 29

ONCO's price has been fluctuating, with some participants still holding a bullish stance despite previous losses.
The company is under scrutiny for alleged dilution of shares, with some participants speculating about the involvement of key individuals, including Eric.
There are rumors of a potential takeover by XBOT, a robotics company, which could lead to ONCO's delisting if not resolved.

Newcomers· Sep 28

Newcomers are buying ONCO, citing its potential to run hard and increase in value, with some predicting it could shoot to $3.
Some users are sharing their experiences with ONCO, including holding through weekends and seeing positive results, and predicting a breakout after a few days of teasing.
There is a premarket alert about ONCO's significant price increase, with a 31% jump from $1.11 to $1.38 in a short period, and users are reacting to this news.

Generated by AI

Onconetix

Social

Sep 29

Bullish· Sep 28

Bearish· Sep 25

Announcements· Apr 15

Technical Analysis· Apr 9

Regulars· Sep 29

Newcomers· Sep 28

12 Health Care Stocks Moving In Friday's After-Market Session - Onconetix (NASDAQ:ONCO), Bullfrog AI Hldg

12 Health Care Stocks Moving In Thursday's After-Market Session - Prime Medicine (NASDAQ:PRME), Onconetix

SRX Global Makes Investment in Onconetix

SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)

CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Onconetix provides $2.5M bridge financing to Realbotix

Also Discussed

Onconetix Inc.

Company Information

Location

12 Health Care Stocks Moving In Friday's After-Market Session - Onconetix (NASDAQ:ONCO), Bullfrog AI Hldg

12 Health Care Stocks Moving In Thursday's After-Market Session - Prime Medicine (NASDAQ:PRME), Onconetix

SRX Global Makes Investment in Onconetix

SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)

CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Onconetix provides $2.5M bridge financing to Realbotix

Also Discussed

Social

Sep 29

Bullish· Sep 28

Bearish· Sep 25

Announcements· Apr 15

Technical Analysis· Apr 9

Regulars· Sep 29

Newcomers· Sep 28